Korean Ministry Grants Approval to GC Biopharma's BARYTHRAX Anthrax Vaccine
With the approval by MFDS, BARYTHRAX has become Korea's 39th novel drug.
Anthrax | 09/04/2025 | By Abha
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy